The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,246.00
Bid: 12,254.00
Ask: 12,256.00
Change: -72.00 (-0.58%)
Spread: 2.00 (0.016%)
Open: 12,324.00
High: 12,406.00
Low: 12,246.00
Prev. Close: 12,318.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 7-Oil extends gains on vaccine hopes, shrugs off U.S. inventory build

Wed, 25th Nov 2020 03:25

(Updates prices, adds latest news on OPEC+)

By Bozorgmehr Sharafedin

LONDON, Nov 25 (Reuters) - Oil prices climbed for a fourth
straight session on Wednesday, shrugging off a report showing
U.S. crude inventories rose more than expected and extending a
rally driven by hopes that a COVID-19 vaccine will boost fuel
demand.

Brent crude rose 43 cents, or 0.9%, at $48.29 a
barrel by 1442 GMT, adding to a 4% gain the previous session.

U.S. West Texas Intermediate crude gained 53 cents,
or 1.2%, to $45.44, after rising more than 4% on Tuesday.

"Crude oil prices are trading at their highest levels since
early March, supported by positive market sentiment as a result
of vaccine news and strong oil demand in Asia," said UBS oil
analyst Giovanni Staunovo.

"We maintain our bullish outlook for next year and target
Brent to hit $60 per barrel at the end of 2021," he added.

AstraZeneca said on Monday its COVID-19 vaccine
could be up to 90% effective, providing another weapon in the
fight to control the pandemic.

A weaker dollar also supported crude prices as a lower
greenback makes oil less expensive for buyers holding other
currencies.

"The recent depreciation of the U.S. dollar has helped
temper the impact of surging oil prices for some of the world’s
largest consumers of energy," said Stephen Brennock of broker
PVM.

Brent has moved into backwardation, a market structure in
which oil for immediate delivery costs more than supply later.
Backwardation encourages inventories to be drawn down and
suggests lingering fears about a glut have receded.

Brent futures for February delivery were trading 13 cents
above January contracts <LCOc1-LCOc2>, the highest since July.

Investors were unpeturbed by Tuesday's data from the
American Petroleum Institute (API) showing U.S. crude stocks
rose by 3.8 million barrels in the week to Nov. 20 to around 490
million barrels, a higher level than forecast.

Official U.S. inventory data is due out on Wednesday.

"Positive vaccine news and swift deployment views are behind
a significant part of this move in the curve, supported by
increasingly firm beliefs by the market that OPEC+ will extend
its current output targets for Q1 2021," said Rystad Energy’s
analyst Bjornar Tonhaugen.

OPEC+, made up of the Organization of the Petroleum
Exporting Countries (OPEC) and allies including Russia, is
leaning towards delaying next year's planned increase in output
despite a rise in prices, three sources close to OPEC+ said.

(Reporting by Bozorgmehr Sharafedin in London; additional
reporting by Aaron Sheldrick in Tokyo; Editing by Jason Neely
and Edmund Blair)

More News
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.